Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Gritstone Raises $102m To Climb Cancer Vaccine Mountain

This article was originally published in Scrip

Executive Summary

Just as rock climbers use gritstones to scale massive peaks, the San Francisco-based startup Gritstone Oncology raised $102m for the development of neoantigen-containing cancer vaccines that may help the immune system mount a targeted attack against tumors.

Advertisement

Related Content

Advaxis Advances Personalized Cancer Vaccines With Eye On Manufacturing Time, Cost
BIO: Biotech Funding Captured By Oncology

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register